Revista Espanola de Quimioterapia
Published by Sociedad Espanola de Quiminoterapia
ISSN : 0214-3429 eISSN : 1988-9518
Abbreviation : Rev. Espanola Quimioter.
Aims & Scope
The official journal of the Sociedad Española de Quimioterapia (Spanish Society of Chemotherapy), publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents primarily in human medicine.
Authors sign an exclusive license agreement, where authors have copyright but license exclusive rights in their article to the Publisher.
All manuscripts are free open access.
Revista Española de Quimioterapia includes the following sections: reviews, original articles, brierf reports, letters, and consensus documents.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 2.2 |
| 2024 | 1.90 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.505 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 35 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Apc url
- License
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Insights for COVID-19 in 2023
Citation: 66
Authors: Francisco Javier, Manuel, José MarÃa, Santiago, Fernando, Julián, Rafael, Pilar, Alejandra, Alberto, Teresa, Javier, Juan, Mari Cruz, Emilio
-
New variants of SARS-CoV-2
Citation: 51
Authors: Rafael, Pilar, Alejandra, Alberto, Javier, Juan, Teresa, Mari Cruz, Francisco Javier, Manuel, José MarÃa, Santiago, Fernando, Julián, Emilio
-
Pharmacological treatment of COVID-19: an opinion paper
Citation: 50
Authors: Alberto, Javier, Juan, Teresa, Mari Cruz, Francisco Javier, Manuel, José MarÃa, Santiago, Fernando, Julián, Rafael, Pilar, Alejandra, Emilio
-
Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings
Citation: 49
Authors: Francisco Javier, Pablo, Jesús, Juan Carlos, Raquel, José, Carlos, Jesús, Rafael, Cristina, Mar, Fernando, Rafael, Julio, Juan, Cristina, Montserrat, Juan Emilio, Francisco Javier, José MarÃa, Patricia, Elena, Mamiko, Juan, Marta, José Antonio, Antonio
-
Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination
Citation: 48
Authors: Jordi, Carla
-
Temporary hospitals in times of the COVID pandemic. An example and a practical view
Citation: 41
Authors: Francisco Javier, Jesús, Antonio, Raquel, Juan, Gonzalo, Jesús, Ruth, Pablo, Marcos, Fernando, Pablo, Jesús, Javier
-
Monkeypox in humans: a new outbreak
Citation: 37
Authors: Mari Cruz, Francisco Javier, Manuel, José MarÃa, Santiago, Fernando, Julián, Rafael, Pilar, Alejandra, Alberto, Teresa, Javier, Juan, Patricia, Maricela, Pilar, Almudena, Alejandro, Antonio, Emilio
-
Recommendations on the use of azole antifungals in hematology-oncology patients
Citation: 31
Authors: José Ramón, José, José, Lourdes, Jaime, Mi, Lucrecia, José MarÃa, Antonio, Carlos, Isabel, Jesús, Miguel, Carlota, Teresa, Carolina, Montserrat, MarÃa, Pedro, Carlos
-
Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?
Citation: 29
Authors: Alejandro, Patricia, Rodrigo, Pedro, Pilar, Iker, Carlos, Jordi, Emilio